Report of Two Cases of Pediatric IgG4-Related Lymphadenopathy (IgG4-LAD): IgG4-Related Disease (IgG4-RD) or a Distinct Clinical Pathological Entity?
Abstract
:1. Introduction
2. Case Reports
3. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Stone, J.H.; Zen, Y.; Deshpande, V. IgG4-related disease. N. Engl. J. Med. 2012, 366, 539–551. [Google Scholar] [CrossRef] [PubMed]
- Hamano, H.; Kawa, S.; Horiuchi, A.; Unno, H.; Furuya, N.; Akamatsu, T.; Fukushima, M.; Nikaido, T.; Nakayama, K.; Usuda, N.; et al. High Serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 2001, 344, 732–738. [Google Scholar] [CrossRef]
- Uchida, K.; Masamune, A.; Shimosegawa, T.; Okazaki, K. Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009. Int. J. Rheumatol. 2012, 2012, 358371. [Google Scholar] [CrossRef]
- Kamisawa, T.; Zen, Y.; Pillai, S.; Stone, J.H. IgG4-related disease. Lancet 2015, 385, 1460–1671. [Google Scholar] [CrossRef]
- Umehara, H.; Okazaki, K.; Masaki, Y.; Kawano, M.; Yamamoto, M.; Saeki, T.; Matsui, S.; Yoshino, T.; Nakamura, S.; Kawa, S.; et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod. Rheumatol. 2012, 22, 21–30. [Google Scholar] [CrossRef]
- Wallace, Z.S.; Naden, R.P.; Chari, S.; Choi, H.; Della-Torre, E.; Dicaire, J.-F.; Hart, P.A.; Inoue, D.; Kawano, M.; Khosroshahi, A.; et al. For the American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020, 72, 7–19. [Google Scholar] [CrossRef]
- Karim, F.; Loeffen, J.; Bramer, W.; Westenberg, L.; Verdijk, R.; van Hagen, M.; van Laar, J. IgG4-related disease: A systematic review of this unrecognized disease in pediatrics. Pediatr. Rheumatol. Online J. 2016, 14, 18. [Google Scholar] [CrossRef]
- Mainardi, C.; Pizzi, M.; Marzollo, A.; Carraro, E.; Boaro, M.P.; Mussolin, L.; Massano, D.; Tazzoli, S.; Onofrillo, D.; Cesaro, S.; et al. Pediatric IgG4-related lymphadenopathy: A rare condition associated with autoimmunity and lymphoproliferative disorders. Pediatr. Allergy Immunol. 2020, 31, 332–336. [Google Scholar] [CrossRef]
- Khosroshahi, A.; Wallace, Z.S.; Crowe, J.L.; Akamizu, T.; Azumi, A.; Carruthers, M.N.; Chari, S.T.; Della Torre, E.; Frulloni, L.; Goto, H.; et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015, 67, 1688–1699. [Google Scholar] [CrossRef]
- Khosroshahi, A.; Carruthers, M.; Deshpande, V.; Unizony, S.; Bloch, D.B.; Stone, J.H. Rituximab for the treatment of IgG4- related disease: Lessons from ten consecutive patients. Medicine 2012, 91, 57–66. [Google Scholar] [CrossRef]
- Brito-Zeron, P.; Ramos-Casals, M.; Bosch, X.; Stone, J.H. The clinical spectrum of IgG4-related disease. Autoimmun. Rev. 2014, 13, 1203–1210. [Google Scholar] [CrossRef] [PubMed]
- Smerla, R.G.; Rontogianni, D.; Fragoulis, G.E. Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report. Clin. Rheumatol. 2018, 37, 1721–1727. [Google Scholar] [CrossRef] [PubMed]
- Akca, U.K.; Atalay, E.; Cüceoğlu, M.K.; Şener, S.; Balık, Z.; Başaran, O.; Batu, E.D.; Karadağ, O.; Özen, S.; Bilginer, Y. IgG4-related disease in pediatric patients: A single-center experience. Rheumatol. Int. 2022, 42, 1177–1185. [Google Scholar] [CrossRef]
- Cheuk, W.; Yuen, H.K.; Chu, S.Y.; Chiu, E.K.; Lam, L.K.; Chan, J.K. Lymphadenopathy of IgG4-related sclerosing disease. Am. J. Surg. Pathol. 2008, 32, 671–681. [Google Scholar] [CrossRef] [PubMed]
- Wu, P.H.; Chang, Y.C.; Liao, L.J. IgG4-Related Disease Presenting as Cervical Lymphadenopathy. J. Med. Ultrasound. 2019, 27, 43–46. [Google Scholar]
- Corujeira, S.; Ferraz, C.; Nunes, T.; Fonseca, E.; Vaz, L.G. Severe IgG4-Related Disease in a Young Child: A Diagnosis Challenge. Case Rep. Pediatr. 2015, 2015, 140753. [Google Scholar] [CrossRef]
- Abraham, M.; Khosroshahi, A. Diagnostic and treatment workup for IgG4-related disease. Expert Rev. Clin. Immunol. 2017, 13, 867–875. [Google Scholar] [CrossRef]
- Sato, Y.; Yoshino, T. IgG4-Related Lymphadenopathy. Int. J. Rheumatol. 2012, 2012, 572539. [Google Scholar] [CrossRef] [PubMed]
- Sato, Y.; Kojima, M.; Takata, K.; Morito, T.; Asaoku, H.; Takeuchi, T.; Mizobuchi, K.; Fujihara, M.; Kuraoka, K.; Nakai, T.; et al. Systemic IgG4-related lymphadenopathy: A clinical and pathologic comparison to multicentric Castleman’s disease. Mod. Pathol. 2009, 22, 589–599. [Google Scholar] [CrossRef] [PubMed]
- Sasaki, T.; Akiyama, M.; Kaneko, Y.; Mori, T.; Yasuoka, H.; Suzuki, K.; Yamaoka, K.; Okamoto, S.; Takeuchi, T. Distinct features distinguishing IgG4-related disease from multicentric Castleman’s disease. RMD Open 2017, 3, e000432. [Google Scholar] [CrossRef] [PubMed]
- Gaidano, G.; Pastore, C.; Gloghini, A.; Volpe, G.; Capello, D.; Polito, P.; Vaccher, E.; Tirelli, U.; Saglio, G.; Carbone, A. Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia. Leuk Lymphoma 1997, 24, 257–266. [Google Scholar] [CrossRef] [PubMed]
- Dispenzieri, A.; Fajgenbaum, D.C. Overview of Castleman disease. Blood 2020, 135, 1353–1364. [Google Scholar] [CrossRef]
- Wang, H.W.; Pittaluga, S.; Jaffe, E.S. Multicentric Castleman disease: Where are we now? Semin. Diagn Pathol. 2016, 33, 294–306. [Google Scholar] [CrossRef] [PubMed]
- Weiss, L.M.; O’Malley, D.P. Benign lymphadenopathies. Mod. Pathol. 2013, 26, S88–S96. [Google Scholar] [CrossRef] [PubMed]
- Morra, D.E.; Pierson, S.K.; Shilling, D.; Nemat, S.; Appiani, C.; Guilfoyle, M.; Tendler, C.; van Rhee, F.; Fajgenbaum, D.C. Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: Secondary analyses of phase II clinical trial data. Br. J. Haematol. 2019, 184, 232–241. [Google Scholar] [CrossRef] [PubMed]
- Azari-Yaam, A.; Abdolsalehi, M.R.; Vasei, M.; Safavi, M.; Mehdizadeh, M. Rosai-Dorfman Disease: A Rare Clinicopathological Presentation and Review of the Literature. Head Neck Pathol. 2021, 15, 352–360. [Google Scholar] [CrossRef]
- Foucar, E.; Rosai, J.; Dorfman, R. Sinus histiocytosis with massive lymphadenopathy Rosai-Dorfman disease: Review of the entity. Semin. Diagn Pathol. 1990, 7, 19–73. [Google Scholar]
- Cangelosi, J.J.; Prieto, V.G.; Ivan, D. Cutaneous Rosai-Dorfman disease with increased number of eosinophils: Coincidence or histologic variant? Arch. Pathol. Lab. Med. 2011, 135, 1597–1600. [Google Scholar] [CrossRef]
- Menon, M.P.; Evbuomwan, M.O.; Rosai, J.; Jaffe, E.S.; Pittaluga, S. A subset of RosaiDorfman disease cases show increased IgG4-positive plasma cells: Another red herring or a true association with IgG4-related disease? Histopathology 2014, 64, 455–459. [Google Scholar] [CrossRef]
- Bonetti, F.; Chilosi, M.; Menestrina, F.; Scarpa, A.; Pelicci, P.G.; Amorosi, E.; Fiore-Donati, L.; Knowles, D.M. Immunohistological analysis of RosaiDorfman histiocytosis: A disease of S100 + CD1-histiocytes. Virchows Arch. A Pathol. Anat. Histopathol. 1987, 411, 129–135. [Google Scholar] [CrossRef]
- Chen, L.Y.C.; Mattman, A.; Seidman, M.A.; Carruthers, M.N. IgG4-related disease: What a hematologist needs to know. Haematologica 2019, 104, 444–455. [Google Scholar] [CrossRef] [PubMed]
- Thorne, I.; Sutcliffe, N. Sjögren’s syndrome. Br. J. Hosp. Med. 2017, 78, 438–442. [Google Scholar] [CrossRef] [PubMed]
- Sève, P.; Pacheco, Y.; Durupt, F.; Jamilloux, Y.; Gerfaud-Valentin, M.; Isaac, S.; Boussel, L.; Calender, A.; Androdias, G.; Valeyre, D.; et al. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells 2021, 10, 766. [Google Scholar] [CrossRef] [PubMed]
- Ohshima, K.; Sato, Y.; Yoshino, T. A case of IgG4-related dacryoadenitis that regressed without systemic steroid administration. J. Clin. Exp. Hematop. 2013, 53, 53–56. [Google Scholar] [CrossRef] [PubMed]
- Maritati, F.; Peyronel, F.; Vaglio, A. IgG4-related disease: A clinical perspective. Rheumatology 2020, 59 (Suppl. S3), iii123–iii131. [Google Scholar] [CrossRef]
- Martinez, L.L.; Friedländer, E.; Van Der Laak, J.A.W.M.; Hebeda, K.M. Abundance of IgG4+ Plasma Cells in Isolated Reactive Lymphadenopathy Is No Indication of IgG4-Related Disease. Am. J. Clin. Pathol. 2014, 142, 459–466. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Meli, M.; Arrabito, M.; Salvatorelli, L.; Soma, R.; Presti, S.; Licciardello, M.; Miraglia, V.; Scuderi, M.G.; Belfiore, G.; Magro, G.; et al. Report of Two Cases of Pediatric IgG4-Related Lymphadenopathy (IgG4-LAD): IgG4-Related Disease (IgG4-RD) or a Distinct Clinical Pathological Entity? Children 2022, 9, 1472. https://doi.org/10.3390/children9101472
Meli M, Arrabito M, Salvatorelli L, Soma R, Presti S, Licciardello M, Miraglia V, Scuderi MG, Belfiore G, Magro G, et al. Report of Two Cases of Pediatric IgG4-Related Lymphadenopathy (IgG4-LAD): IgG4-Related Disease (IgG4-RD) or a Distinct Clinical Pathological Entity? Children. 2022; 9(10):1472. https://doi.org/10.3390/children9101472
Chicago/Turabian StyleMeli, Mariaclaudia, Marta Arrabito, Lucia Salvatorelli, Rachele Soma, Santiago Presti, Maria Licciardello, Vito Miraglia, Maria Grazia Scuderi, Giuseppe Belfiore, Gaetano Magro, and et al. 2022. "Report of Two Cases of Pediatric IgG4-Related Lymphadenopathy (IgG4-LAD): IgG4-Related Disease (IgG4-RD) or a Distinct Clinical Pathological Entity?" Children 9, no. 10: 1472. https://doi.org/10.3390/children9101472